Skip to main content

Table 3 Total morbidity and complication rates

From: Implementation of goal-directed fluid therapy during hip revision arthroplasty: a matched cohort study

 

Control group (n = 130)

GDFT group (n = 130)

p

Total morbidity

87 [66.9%]

64 [49.2%]

0.006

Infectious complications

13 [10%]

10 [7.7%]

0.663

Cardiac complications

10 [7.7%]

2 [1.5%]

0.034

Postoperative arrhythmia

9 [6.9%]

1 [0.8%]

0.019

Neurological complications

6 [4.6%]

7 [5.4%]

1.000

Renal complications

2 [1.5%]

2 [1.5%]

1.000

Hemorrhagic complications

80 [61.5%]

56 [43.1%]

0.004